Literature DB >> 1699422

Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis.

R H Hruban1, W E Beschorner, W A Baumgartner, S M Augustine, H Ren, B A Reitz, G M Hutchins.   

Abstract

Accelerated arteriosclerosis has emerged as a major life-threatening complication in long-term survivors of heart transplantation. It has been proposed that accelerated arteriosclerosis is an immune-mediated complication of rejection. We observed a striking endothelialitis in the coronary arteries of two explanted hearts obtained from patients with severe transplant-related accelerated arteriosclerosis. This finding prompted us to review the pathologic changes in the coronary arteries of 23 autopsied patients who had received heart transplants. The infiltrate in these vessels was characterized using immunohistochemical stains for lymphocytes (CD45), macrophages (MAC-387), T lymphocytes (CD45RO), B lymphocytes (L-26), and smooth muscle cells (actin). In addition, a full panel of monoclonal antibodies was used on the fresh-frozen tissue available from one of the two explanted hearts. Ten of the eleven recipients with accelerated arteriosclerosis had a moderate to marked lymphocytic endothelialitis compared to 3 of 14 without transplant-related arteriosclerosis (P less than 0.005). Immunohistochemical staining of the paraffin-embedded material demonstrated that most of the lymphocytes in the subendothelial space of these vessels were T lymphocytes and that this infiltrate was associated with an accumulation of macrophages and a proliferation of smooth muscle cells in the intima. In the explanted heart from which fresh-frozen tissue was available for more detailed cell typing, the T cells marked predominantly as cytotoxic T lymphocytes (CD8+, CD2+). These results suggest that accelerated arteriosclerosis may be mediated, in part, by a cytotoxic T-lymphocyte-directed endothelialitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699422      PMCID: PMC1877542     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

1.  Importance of PDGF receptor expression in accelerated atherosclerosis-chronic rejection.

Authors:  B Fellström; E Dimeny; E Larsson; L Klareskog; G Tufveson; K Rubin
Journal:  Transplant Proc       Date:  1989-08       Impact factor: 1.066

2.  Immunologic control of vascular cell growth in arterial response to injury and atherosclerosis.

Authors:  S Stemme; L Jonasson; J Holm; G K Hansson
Journal:  Transplant Proc       Date:  1989-08       Impact factor: 1.066

3.  Acute vascular rejection involving the major coronary arteries of a cardiac allograft.

Authors:  R L Yowell; E H Hammond; M R Bristow; F S Watson; D G Renlund; J B O'Connell
Journal:  J Heart Transplant       Date:  1988 May-Jun

4.  Control of graft arteriosclerosis in human heart transplant recipients.

Authors:  R B Griepp; E B Stinson; C P Bieber; B A Reitz; J G Copeland; P E Oyer; N E Shumway
Journal:  Surgery       Date:  1977-03       Impact factor: 3.982

5.  The effects of treatment on the arterial lesions of rat and rabbit cardiac allografts.

Authors:  A M Laden
Journal:  Transplantation       Date:  1972-03       Impact factor: 4.939

6.  Cardiac transplantation in man. VII. Cardiac allograft pathology.

Authors:  C P Bieber; E B Stinson; N E Shumway; R Payne; J Kosek
Journal:  Circulation       Date:  1970-05       Impact factor: 29.690

7.  Histopathology of orthotopic canine cardiac homografts.

Authors:  J C Kosek; E J Hurley; R R Lower
Journal:  Lab Invest       Date:  1968-07       Impact factor: 5.662

8.  Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis.

Authors:  M T Grattan; C E Moreno-Cabral; V A Starnes; P E Oyer; E B Stinson; N E Shumway
Journal:  JAMA       Date:  1989 Jun 23-30       Impact factor: 56.272

9.  Experimental induction of atheroarteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet. 3. The role of earlier acquired fibromuscular intimal thickening in the pathogenesis of later developing atherosclerosis.

Authors:  N J Hardin; C R Minick; G E Murphy
Journal:  Am J Pathol       Date:  1973-11       Impact factor: 4.307

10.  Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications.

Authors:  E H Hammond; R L Yowell; S Nunoda; R L Menlove; D G Renlund; M R Bristow; W A Gay; K W Jones; J B O'Connell
Journal:  J Heart Transplant       Date:  1989 Nov-Dec
View more
  31 in total

1.  Graft vascular disease in heart transplant patients.

Authors:  J Mann
Journal:  Br Heart J       Date:  1992-09

2.  Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts.

Authors:  T C Wu; R H Hruban; R F Ambinder; M Pizzorno; D E Cameron; W A Baumgartner; B A Reitz; G S Hayward; G M Hutchins
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

3.  Inducible nitric oxide synthase expression in coronary arteries of transplanted human hearts with accelerated graft arteriosclerosis.

Authors:  A Lafond-Walker; C L Chen; S Augustine; T C Wu; R H Hruban; C J Lowenstein
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

4.  Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo.

Authors:  Y Furukawa; G Becker; J L Stinn; K Shimizu; P Libby; R N Mitchell
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

5.  FK 506 inhibits the development of transplant arteriosclerosis.

Authors:  G D Wu; D V Cramer; F A Chapman; E Cajulis; H K Wang; T E Starzl; L Makowka
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

6.  CD4+ regulatory T cells generated in vitro with IFN-{gamma} and allogeneic APC inhibit transplant arteriosclerosis.

Authors:  Gregor Warnecke; Gang Feng; Ryoichi Goto; Satish N Nadig; Ross Francis; Kathryn J Wood; Andrew Bushell
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

7.  Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation.

Authors:  R H Hruban; P P Long; E J Perlman; G M Hutchins; W A Baumgartner; K L Baughman; C A Griffin
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

8.  Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection.

Authors:  C E Bacchi; C L Marsh; J D Perkins; R L Carithers; J P McVicar; K L Hudkins; C D Benjamin; J M Harlan; R Lobb; C E Alpers
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

Review 9.  Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Authors:  A J Demetris; N Murase; R G Lee; P Randhawa; A Zeevi; S Pham; R Duquesnoy; J J Fung; T E Starzl
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

10.  Pathology of Chronic Rejection: An Overview of Common Findings and Observations About Pathogenic Mechanisms and Possible Prevention.

Authors:  A J Demetris; N Murase; T E Starzl; J J Fung
Journal:  Graft (Georget Tex)       Date:  1998-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.